Skip to main content

Table 2 Number and percentage of adherent adult leukemia patients by ASK-12 subscale and question

From: Exploring behaviors, treatment beliefs, and barriers to oral chemotherapy adherence among adult leukemia patients in a rural outpatient setting

Subscales

Multiple myeloma (N = 20)a

Chronic myeloid leukemia (N = 11)a

Visit 1

Visit 2

Visit 1

Visit 2

A. Inconvenience/forgetfulness

N (%) adherent (strongly disagree and disagree)

N (%) adherent (strongly disagree and disagree)

 Lifestyles

1) I just forget to take my medicines some of the time

13 (65)

16 (80)

6 (55)

8 (73)

2) I run out of my medicines because I don’t get refills on time

18 (90)

18 (90)

8 (73)

9 (82)

3) Taking medicines more than once a day is inconvenient

16 (80)

16 (80)

7 (64)

8 (73)

B. Treatment beliefs

N (%) adherent (strongly agree and agree)

N (%) adherent (strongly agree and agree)

 Attitudes and beliefs

4) I feel confident that each one of my medicines will help me

14 (70)

19 (95)b

10 (91)

10 (91)

5) I know if I am reaching my health goals

14 (70)

18 (90)

10 (91)

10 (91)

 Help from others

6) I have someone I can call with questions about my medicines

18 (90)

18 (90)

10 (91)

11 (100)b

 Talking with healthcare team

7) My doctor/nurse and I work together to make decisions

19 (95)

18 (90)

11 (100)

10 (91)b

C. Behavior

Have You…

N (%) adherent (never or > 3 months ago)

N (%) adherent (never or > 3 months ago)

 Taking medications

8) Taken a medicine more or less often than prescribed?

16 (80)

17 (85)

4 (36)

7 (64)

9) Skipped or stopped taking medicines because you didn’t think it was working?

19 (95)

19 (95)

9 (82)

9 (82)

10) Skipped or stopped taking medicine because it made you feel bad?

20 (100)

20 (100)

9 (82)

10 (91)

11) Skipped, stopped, not refilled or taken less medicine because of the cost?

20 (100)

20 (100)

9 (82)

9 (82)

12) Not had medicine with you when it was time to take it?

15 (75)

16 (80)

8 (73)

9 (82)

  1. a Percentages include 20 multiple myeloma or 11 chronic myeloid leukemia respondents in denominator, respectively
  2. b p-value < 0.05